UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status No longer recruiting
Unique ID issued by UMIN UMIN000006393
Receipt No. R000007568
Scientific Title Cross-sectional study of second-line therapy administration after platinum-based chemotherapy for patients with advanced NSCLC.
Date of disclosure of the study information 2011/09/22
Last modified on 2020/08/19

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Cross-sectional study of second-line therapy administration after
platinum-based chemotherapy for patients with advanced NSCLC.
Acronym Second-line chemotherapy administration for patients with advanced NSCLC, who completed platinum-based "Hyojun" (standard) doublet, In the follow-up period, and at recurrence.(SAPPHIRE)
Scientific Title Cross-sectional study of second-line therapy administration after
platinum-based chemotherapy for patients with advanced NSCLC.
Scientific Title:Acronym Second-line chemotherapy administration for patients with advanced NSCLC, who completed platinum-based "Hyojun" (standard) doublet, In the follow-up period, and at recurrence.(SAPPHIRE)
Region
Japan

Condition
Condition Advanced lung cancer
Classification by specialty
Pneumology Hematology and clinical oncology Chest surgery
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To investigate the proportion of the second-line therapy administration after platinum-based chemotherapy for patients with advanced NSCLC, and explore the reasons and the background factors of the patients who could not take the second-line therapy. We also discuss the strategy for the follow-up of patients after the first-line chemotherapy (maintenance chemotherapy, periodical follow-up without continuing chemotherapy), by comparing the background factors at the beginning of the first and second line chemotherapy.
Basic objectives2 Others
Basic objectives -Others horyuu
Trial characteristics_1 Exploratory
Trial characteristics_2 Pragmatic
Developmental phase Not applicable

Assessment
Primary outcomes Proportion of the patients administered the second-line chemotherapy
Key secondary outcomes 1)Proportion of the patients who had PD for first-line chemotherapy
2)Proportion of the patients who were administered second-line chemotherapy
3)Proportion of the patients who were administered third-line chemotherapy after the second-line chemotherapy
4)Proportion of the patients who were administered second-line chemotherapy after having PD for first-line chemotherapy.
5)Proportion of the patients who were administered second-line chemotherapy after taking maintenance chemotherapy.

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria 1)Patients who were diagnosed as advanced or recurrent NSCLC before this study.
2)Consecutive patients in each institution who had started first-line platinum chemotherapy in combination with third generation agent after April 1, 2010.
Key exclusion criteria 1)Recurrent NSCLC patients who had undergone adjuvant platinum based chemotherapy.
2)Active double cancer.
Target sample size 750

Research contact person
Name of lead principal investigator
1st name Hideo
Middle name
Last name Kunitoh
Organization Mitsui Memorial Hospital
Division name Department of Respiratory Medicine
Zip code 101-8643
Address 1,Kanndaizumi-chou, Chiyoda-ku, Tokyo, 101-8643, Japan
TEL 03-3862-9111
Email no@mail

Public contact
Name of contact person
1st name Akira
Middle name
Last name Yamao
Organization Public Health Research Foundation
Division name Comprehensive Support Project for Clinical Research
Zip code 169-0051
Address 1-1-7, Nishiwaseda, Shinjuku-ku, Tokyo, 169-0051, Japan
TEL 03-5287-2633
Homepage URL http://www.csp.or.jp/
Email info@csp.or.jp

Sponsor
Institute SAPPHIRE Executive committee
Institute
Department

Funding Source
Organization Public Health Research Foundation
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization no
Address no
Tel no
Email nomail

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2011 Year 09 Month 22 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status No longer recruiting
Date of protocol fixation
2010 Year 09 Month 03 Day
Date of IRB
Anticipated trial start date
2010 Year 10 Month 01 Day
Last follow-up date
2013 Year 03 Month 01 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information horyuu

Management information
Registered date
2011 Year 09 Month 22 Day
Last modified on
2020 Year 08 Month 19 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000007568

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.